Skip to main content
Equibles
JNJ logo

JNJ · Johnson & Johnson · Metrics

Track JNJ — free

Use JNJ with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research JNJ.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$270.56 -2.64 (-0.97%) At close · Nov 2 Q3 2026 earnings call transcript
S&P 500 member Russell 1000 member Dow 30 member Rebalance outlook locked
Market Cap
$657.68B
Shares
2.41B
Volume · Nov 2 8.3M Avg daily vol (3M) 6.92M

JNJ metrics

110 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$270.56
Market cap
$657.68B

Price action

20 metrics
Price change (1W)
+3.6%
Price change (30D)
+8.0%
Price change (3M)
+6.6%
Price change (6M)
+20.3%
Price change (YTD)
+32.0%
Price change (1Y)
+44.5%
Trailing year
Price change (5Y)
+67.7%
52-week high
$278.43
52-week low
$186.00
Change from 52-week high
-1.9%
Change from 52-week low
+46.9%
Annualized volatility
20.7%
Annualized volatility (3M)
22.7%
Beta
-0.2
RSI (14D)
60.3
Price vs SMA 50
+2.9%
Price vs SMA 200
+10.6%
Avg volume (3M)
6.90M
Relative volume
1.3
Average dollar volume
$1.82B

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
2.41B

Valuation

12 metrics
P / E (TTM)
41.5
Trailing earnings · reciprocal yield 2.4%
PEG ratio
—
EV / revenue
6.9×
reciprocal yield 14.5%
EV / EBITDA
25.3×
reciprocal yield 4.0%
EV / EBIT
29.6×
reciprocal yield 3.4%
P / sales
6.6×
reciprocal yield 15.1%
P / book
8.1
reciprocal yield 12.4%
FCF yield
3.1%
TTM · current market cap
Buyback yield
1.2%
P / FCF
31.9
reciprocal yield 3.1%
P / operating cash flow
25.1
reciprocal yield 4.0%
Earnings yield
2.4%

Historical valuation

8 metrics
P / E historical average (3Y)
20.7×
reciprocal yield 4.8%
P / E historical average (5Y)
22.8×
reciprocal yield 4.4%
EV / revenue historical average (3Y)
5.1×
reciprocal yield 19.6%
EV / revenue historical average (5Y)
5.0×
reciprocal yield 20.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
1.9%
Trailing 12 months
Payout ratio
—
Shareholder yield
1.2%
Dividend / share (TTM)
$5.28
Dividend growth YoY
+3.9%
Dividend growth streak
5+
Stored dividend history starts 2020
Last ex-dividend
2026-08-25

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-10-13

Profitability

9 metrics
Gross margin
67.6%
Operating margin
—
Trailing 12 months
Net margin
16.2%
Gross profit (TTM)
$67.11B
Operating profit (TTM)
$21.77B
Net income (TTM)
$16.09B
Trailing 12 months
Diluted EPS (TTM)
$6.58
FCF margin
20.7%
Effective tax rate
9.3%

Per share

11 metrics
Revenue per diluted share (TTM)
$40.63
Gross profit per diluted share (TTM)
$27.45
Operating profit per diluted share (TTM)
$7.63
EBITDA per diluted share (TTM)
$8.95
Net income per diluted share (TTM)
$6.59
Operating cash flow per diluted share (TTM)
$10.70
Free cash flow per diluted share (TTM)
$8.42
Capital expenditures per diluted share (TTM)
$2.28
R&D per diluted share (TTM)
$0.63
Stock compensation per diluted share (TTM)
$0.58
Book value per share
—

Growth

11 metrics
Revenue growth YoY
+5.9%
Year over year
Net income growth YoY
-95.9%
Revenue (TTM)
$99.33B
Trailing 12 months
EPS growth YoY
-95.8%
Shares change YoY
+0.8%
Year over year · more shares
Revenue CAGR (3Y)
+5.6%
Revenue CAGR (5Y)
+2.7%
EPS CAGR (3Y)
+17.9%
EPS CAGR (5Y)
+14.9%
FCF CAGR (3Y)
+4.7%
FCF CAGR (5Y)
-0.5%

Quality

14 metrics
Return on equity
19.7%
Return on assets
8.2%
Debt / equity
0.5
Current ratio
1.0
EBITDA (TTM)
$25.54B
Free cash flow (TTM)
$20.59B
Quick ratio
0.7
Interest coverage
—
Net debt / EBITDA
-0.5
Return on invested capital
—
Trailing 12 months
Net cash
−$27.42B
Latest balance sheet
Cash & equivalents
$16.91B
Total assets
$197.43B
Total debt
$44.65B

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$26.16B
Capital expenditures (TTM)
$5.57B
R&D (TTM)
$1.53B
SG&A (TTM)
$25.50B
Stock compensation (TTM)
$1.42B
R&D / revenue
1.5%
Stock compensation / revenue
1.4%

Ownership (13F)

9 metrics
13F filers
4,733
13F filer change QoQ
+45
Institutional ownership
76.2%
Conviction holders (share of 13F filers)
6.7%
Crowding (high-turnover and private-fund holders)
8.2%
Private-fund adviser ownership
7.9%
Active holders' share change QoQ
+0.3%
Holder tenure
19.0
Price vs estimated holder cost
+28.5%

Ownership (registered funds)

1 metrics
Index-fund ownership
17.8%

Short interest

3 metrics
Short interest
0.7%
Latest settlement · 2.0 days to cover
Days to cover
2.0d
Short-squeeze score
36 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$61.99M
Insider-sentiment score
17 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 200406 CUSIP 478160104 13F (30d) 2453 filings 2347 filers Visit website Investor relations